Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact
Biomarker Discovery & Development | Whitepapers & Reports

Gryolab - Selective and Robust Biomarker Quantification

28 February 2023

The use of biomarkers in biotherapeutic development to monitor drug pharmacodynamics, safety, and efficacy has been steadily increasing in an FDA-supported effort to guide decision making and improve the success of new therapeutics in clinical studies.

Open document in a new tab

Related Resources

A New Golden Age for Target Identification: Accessing the Novel Druggable Space with Discovery Proteomics

On-demand webinar presented by Mo Jain, MD, PhD, Founder and CEO, Sapient and Jonathan Usuka, PhD, MBA Chief Business Officer, Sapient
Read More

Abcam: Keep your research moving with our tools

Read More

Unlock access to the latest research insights

Read More